Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study - Wikidata - wikimedia - TriplyDB

Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study

Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study

http://www.wikidata.org/entity/Q36868309

about

Adipokines, metabolic syndrome and rheumatic diseases Inter-relationships between the severity of metabolic syndrome, insulin and adiponectin and their relationship to future type 2 diabetes and cardiovascular disease Combined Effect of Initial and Longitudinal Increases in γ-Glutamyltransferase on Incident Metabolic Syndrome: ARIRANG Study.Low serum adiponectin level is associated with metabolic syndrome and is an independent marker of peripheral arterial stiffness in hypertensive patients.The Efficacy of Fimasartan for Cardiovascular Events and Metabolic Syndrome (K-MetS Study): Rationale, Design and Participant Characteristics.Cut-off value of total adiponectin for managing risk of developing metabolic syndrome in male Japanese workers.Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample Addition of N-terminal pro-B-type natriuretic peptide levels to electrocardiography criteria for detection of left ventricular hypertrophy: the ARIRANG study.Ezetimibe ameliorates atherogenic lipids profiles, insulin resistance and hepatocyte growth factor in obese patients with hypercholesterolemia.A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study.Incremental Predictive Value of Serum AST-to-ALT Ratio for Incident Metabolic Syndrome: The ARIRANG Study.Prevalence, associated factors and heritabilities of metabolic syndrome and its individual components in African Americans: the Jackson Heart Study High Serum Irisin Level as an Independent Predictor of Diabetes Mellitus: A Longitudinal Population-Based Study Fatty liver index as a simple predictor of incident diabetes from the KoGES-ARIRANG study.Reduced circulating adiponectin levels are associated with the metabolic syndrome independently of obesity, lipid indices and serum insulin levels: a cross-sectional study Association between Urine Albumin-to-Creatinine Ratio within the Normal Range and Incident Hypertension in Men and Women.A prospective study of epicardial adipose tissue and incident metabolic syndrome: the ARIRANG study.Comparison of salivary and plasma adiponectin and leptin in patients with metabolic syndrome Impact of Serum Leptin to Adiponectin Ratio on Regression of Metabolic Syndrome in High-Risk Individuals: The ARIRANG Study.Clinical biomarkers in metabolic syndrome.Cohort Profile: The Korean Genome and Epidemiology Study (KoGES) Consortium.Response to Comment on: Kim et al. Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG Study. Diabetes Care 2013;36:1547-1553.Comment on: Kim et al. Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG Study. Diabetes Care 2013;36:1547-1553.Gender-specific differences in the incidence of microalbuminuria in metabolic syndrome patients after treatment with fimasartan: The K-MetS study.Low Plasma Adiponectin Concentrations Predict Increases in Visceral Adiposity and Insulin Resistance.A prospective study of the association between total sleep duration and incident hypertension.Adiponectin exerts a potent anti-arthritic effect and insulin resistance in collagen-induced arthritic rats.Plasma Neuregulin 4 Levels Are Associated with Metabolic Syndrome in Patients Newly Diagnosed with Type 2 Diabetes Mellitus.Meta-Analysis of Adiponectin as a Biomarker for the Detection of Metabolic Syndrome

P2860

Q26865268-378B2042-341E-472B-BCA6-938C5357C5CD Q30276888-C5A796DD-18DB-490B-8D12-47D81CC460CC Q33734994-2100D74B-E8C6-43D2-A7DF-0ADB929543C4 Q33851063-1C2BBC56-E781-419E-8377-F03EB6ED6AAC Q35043165-846D92E2-FCC2-4B6A-B2DF-2369C77DEA45 Q35112116-CD7BBEBD-724C-4A86-B19B-226FE96978EB Q35137985-979A6B74-6093-47D0-B565-97AF40526A88 Q35198554-00C0DA1E-9F65-4A13-9229-259BE32F706D Q35562193-5FCC5650-90DF-4681-AAAD-C38147587A23 Q35855651-11290FF7-98AB-4C69-AF34-0AB67DF35C93 Q36113062-A8C2E025-5CD0-423E-ABDC-9FEFA346CE72 Q36258843-26AE5FB4-B62D-43D8-9F9E-D3170F9A8081 Q37003628-4C4702AA-8510-409A-8277-F7E7FCC61625 Q37165128-790440EA-330D-4F19-9D76-E230A625EAB1 Q37212046-E5E07415-E77F-43D9-B3ED-D77D0CDECAC4 Q37231894-F8F4F8FC-BD49-46C3-9ACB-A75A2A0144FF Q37378758-8399C02F-2F22-41A0-8D11-E1F82B287114 Q37588834-460C8F89-F9BA-496F-BA90-D387C3F51DE3 Q37622148-51D647A2-91BE-40E8-9083-36DB6886AC15 Q38171244-6F96DC00-8349-4363-945C-1E6F02ECC0B5 Q40796849-D30DDF11-8FC1-4E17-8D88-67AEC8740615 Q42561133-FD6E4718-1E8F-4A0C-B5C5-286163B58071 Q42561195-40516A1A-67C9-4621-A5FC-9BAD7CB3DEE3 Q47112716-DF53D147-330B-4A66-A4AA-069DA1A8497C Q47188498-ECD72945-2FA6-43CE-AB52-21C2DBACA6F7 Q47780160-73A3AB1D-01D4-4BF7-B740-03704562C562 Q48331415-59197467-FE99-4768-B47D-517B44BE25E1 Q55014592-2897E436-C7CC-4312-9A26-A99ED7287785 Q58553707-3BB50C18-3181-4CDF-95D0-F158DA42652B

P2860

Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study

http://www.wikidata.org/entity/Q36868309

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study

@en

type

label

Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study

@en

prefLabel

Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study

@en

P1433

Q36868309-C1E3FA6B-7F2C-4596-BE58-B0B677805B77

P1476

Q36868309-4D4F375B-3246-4646-B75B-E2A2197C8C15

P2093

Q36868309-268BC451-5977-4904-9B68-E117445A3CBD

Q36868309-41AE9238-7ADA-40B5-8B0B-53CB05CD71F8

Q36868309-51DA559C-3C19-46E1-B309-B4D410C29FA7

Q36868309-67B06AE5-D743-4B8E-86E1-51BF0187A7E8

Q36868309-67E2D387-438E-4744-84EC-1B6E682F90A6

Q36868309-7CBE193D-DE14-4A6B-B4DF-9B3D886CB7EE

Q36868309-9482AC97-0DEA-48D3-98CF-C7EC9869C3EF

Q36868309-9CB094DE-E89E-4ECC-93EE-56C4B18A9A2A

Q36868309-C3452842-9399-40F3-880B-790D36E53FCA

Q36868309-DBFF1FD6-54C3-4A2A-997A-6A1937357A65

P2860

Q36868309-0A9AB118-BB11-4537-BAC6-45EB6E14A0BB

Q36868309-12683492-774D-4B9A-83F8-34FA712A22C4

Q36868309-198DAB5D-B07F-4908-B8F5-6593FFDF213B

Q36868309-2507AC6E-A524-4488-9943-1DAC8E5162E1

Q36868309-30D5CE2B-5769-49DC-9CCE-B783F225E505

Q36868309-320ED729-5A7A-42A2-B63B-6131F6416848

Q36868309-3A7341E8-A62C-4EDE-BE66-5A97B1D0B881

Q36868309-3C5BE874-B7E8-4156-B6F7-BEEBD616FBC3

Q36868309-3DEEF200-A372-442C-9435-B45A7D366D9A

Q36868309-422AF0C1-79CC-42D2-A223-20EBF8ECC9FF

P304

Q36868309-A2F41082-1850-46C5-8CAD-CBB6C2713C8D

P31

Q36868309-2B59E19C-D161-4E49-8413-2D41DCBDC5FA

P356

Q36868309-A910B849-411D-456A-9EAD-FAFC38504E19

P407

Q36868309-656BE190-6171-4EBD-8E6D-4A7507A51BD3

P433

Q36868309-6B9DC8E3-4C58-4507-AA39-E1E31FF70464

P478

Q36868309-AFE9AA02-63CC-4B0C-B859-99E1B7E38641

P577

Q36868309-ECDAB083-CC86-4640-BE71-A8316E42270A

P5875

Q36868309-28970D13-6B03-44B0-BB15-8FDB3118EFAC

P698

Q36868309-8757B268-0167-448B-B3D9-D00BAD28F9A4

P921

Q36868309-DFDBD500-9335-4FCD-8025-44E19819422F

P932

Q36868309-35E2C707-714B-46D2-AE00-1A0104DE94DD

P356

P1433

P1476

Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study

@en

P2093

Byung-Su Yoo

http://www.w3.org/2001/XMLSchema#string

Eliseo Guallar

http://www.w3.org/2001/XMLSchema#string

Jang-Young Kim

http://www.w3.org/2001/XMLSchema#string

Jin-Ha Yoon

http://www.w3.org/2001/XMLSchema#string

Jong-Ku Park

http://www.w3.org/2001/XMLSchema#string

Junghan Yoon

http://www.w3.org/2001/XMLSchema#string

Kyung-Hoon Choe

http://www.w3.org/2001/XMLSchema#string

Sang-Baek Koh

http://www.w3.org/2001/XMLSchema#string

Seung-Hwan Lee

http://www.w3.org/2001/XMLSchema#string

Song Vogue Ahn

http://www.w3.org/2001/XMLSchema#string

P2860

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

The metabolic syndrome

Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies.

The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

Adiponectin--a key adipokine in the metabolic syndrome.

Adiponectin and metabolic syndrome.

Relationships between serum adiponectin with metabolic syndrome and components of metabolic syndrome in non-diabetic Koreans: ARIRANG study

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007.

P304

1547-1553

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC12-0223

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234012010

http://www.w3.org/2001/XMLSchema#string

P698

23275369

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

3661834

http://www.w3.org/2001/XMLSchema#string